Source: VistaGen Therapeutics, Inc.
Date: October 15, 2008
Summary:
Researchers from VistaGen Therapeutics, together with Dr. Gordon Keller and his team of scientists from Toronto's McEwen Centre for Regenerative Medicine and the Mount Sinai School of Medicine, have successfully identified key biochemical pathways involved in directing embryonic stem (ES) cells to become heart cells. The research was published recently in the online edition of the scientific journal Nature Biotechnology, in a paper entitled "Notch signaling re-specifies the hemangioblast to a cardiac fate."
